AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Prospective Descriptive Study of Injuries Associated to Anterior Shoulder Dislocations in Patients Over 40 Years

Recruitingn/aAges 40 Years - anyAllCorporacion Parc Tauli
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The glenohumeral joint has the highest rate of dislocation of the whole body, due to its high mobility and the special characteristics of its anatomy. It is estimated that every year between 1-2% of the population will suffer from glenohumeral dislocation. The vast majority of studies are based on young patients under the age of 40, given that at this age they have the higher incidence and at the same time, they have higher redislocation index. However, the investigators are in front of a more active population with a longer life expectancy. That is why the cases of anterior glenohumeral dislocations are increasing in people older than 40 years. Given that most studies focus on younger patients, the investigators lack knowledge about which injuries are associated with dislocation at this age and whether these influence its clinical evolution.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * More than 40 years old * First episode of traumatic anterior gelnohumeral dislocation seen in Rx * Acceptance to be checked over 2 years * Acceptance to be submitted to TAC, NMR, EMG and Bilateral Ultrasound Exclusion Criteria: * Previous fractures in this extremity * Previous neurovascular lesions in this extremity * Other associated lesions * Cognitive alterations or dementia which prevent completing the protocols. Patients with \<14 points in Mini-mental test.
๐Ÿ’Š

What it tests

  • Reduction
๐Ÿ“

Where

1 site
Hospital Parc Taulรญ
Sabadell, Spain
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy